ID: ALA5201100

Max Phase: Preclinical

Molecular Formula: C11H10N2O2S

Molecular Weight: 234.28

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=C2/SC(N)=NC2=O)cc1

Standard InChI:  InChI=1S/C11H10N2O2S/c1-15-8-4-2-7(3-5-8)6-9-10(14)13-11(12)16-9/h2-6H,1H3,(H2,12,13,14)/b9-6+

Standard InChI Key:  VLWZKYOCVFKBBT-RMKNXTFCSA-N

Associated Targets(Human)

Xanthine dehydrogenase 1038 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 234.28Molecular Weight (Monoisotopic): 234.0463AlogP: 1.62#Rotatable Bonds: 2
Polar Surface Area: 64.68Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.86CX LogP: 1.31CX LogD: 1.31
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.79Np Likeness Score: -1.11

References

1. Zhang L, Tian J, Cheng H, Yang Y, Yang Y, Ye F, Xiao Z..  (2022)  Identification of novel xanthine oxidase inhibitors via virtual screening with enhanced characterization of molybdopterin binding groups.,  230  [PMID:35063733] [10.1016/j.ejmech.2022.114101]

Source